140 related articles for article (PubMed ID: 7652764)
41. Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells.
Kosiewicz MM; Streilein JW
J Immunol; 1996 Sep; 157(5):1905-12. PubMed ID: 8757308
[TBL] [Abstract][Full Text] [Related]
42. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
[TBL] [Abstract][Full Text] [Related]
43. Secondary delayed type hypersensitivity to H-2 subregion-coded alloantigens.
Bianchi AT; Hussaarts-Odijk LM; Benner R
Immunobiology; 1985 Sep; 170(3):192-202. PubMed ID: 3863787
[TBL] [Abstract][Full Text] [Related]
44. Immunologic privilege evoked by histoincompatible intracameral retinal transplants.
Jiang LQ; Streilein JW
Reg Immunol; 1990-1991; 3(3):121-30. PubMed ID: 2098067
[TBL] [Abstract][Full Text] [Related]
45. Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases.
Niederkorn JY; Streilein JW
J Immunol; 1982 Jun; 128(6):2470-4. PubMed ID: 6804562
[TBL] [Abstract][Full Text] [Related]
46. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation.
Skelsey ME; Mayhew E; Niederkorn JY
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5242-51. PubMed ID: 14638723
[TBL] [Abstract][Full Text] [Related]
47. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
D'Orazio TJ; Niederkorn JY
J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
[TBL] [Abstract][Full Text] [Related]
48. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
49. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
Farooq SM; Ashour HM
Brain Behav Immun; 2014 Jan; 35():64-9. PubMed ID: 24095895
[TBL] [Abstract][Full Text] [Related]
50. Regulation of delayed-type hypersensitivity. VII. The role of I-J subregion gene products in the inhibition of delayed-type hypersensitivity to major histocompatibility antigens by specific suppressor T cells.
Liew FY
Eur J Immunol; 1981 Nov; 11(11):883-8. PubMed ID: 6173227
[TBL] [Abstract][Full Text] [Related]
51. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID.
Geiger K; Sarvetnick N
J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729
[TBL] [Abstract][Full Text] [Related]
52. Induction of anterior chamber-associated immune deviation with lymphoreticular allogeneic cells.
Okamoto S; Hara Y; Streilein JW
Transplantation; 1995 Feb; 59(3):377-81. PubMed ID: 7871568
[TBL] [Abstract][Full Text] [Related]
53. Abrogation of anterior-chamber-induced suppression of delayed-type hypersensitivity responses by monoclonal anti-I-J antibodies.
Niederkorn JY; Waltenbaugh C; Streilein JW
Transplantation; 1984 Jun; 37(6):623-5. PubMed ID: 6233772
[No Abstract] [Full Text] [Related]
54. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
55. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye.
Skelsey ME; Mayhew E; Niederkorn JY
Immunology; 2003 Sep; 110(1):18-29. PubMed ID: 12941137
[TBL] [Abstract][Full Text] [Related]
56. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen.
Ferguson TA; Herndon JM
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3085-93. PubMed ID: 8206727
[TBL] [Abstract][Full Text] [Related]
57. Eye-mediated induction of specific immune tolerance to encephalitogenic antigens.
Farooq SM; Ashour HM
CNS Neurosci Ther; 2013 Jul; 19(7):503-10. PubMed ID: 23522052
[TBL] [Abstract][Full Text] [Related]
58. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
Wenkel H; Chen PW; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
[TBL] [Abstract][Full Text] [Related]
59. Lipopolysaccharide-induced suppression of DTH-reactivity to histocompatibility antigens. I. Kinetic aspects and specificity.
Molendijk A; Bril H; Hussaarts-Odijk LM; van Gurp RJ; Benner R
Immunobiology; 1988 Feb; 176(3):255-71. PubMed ID: 2966104
[TBL] [Abstract][Full Text] [Related]
60. Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation.
Zhang Y; Zhang M; Zhao S; Li X; Jia Z; Zhang L; Han ZC; Zhang X
Int Immunopharmacol; 2013 Jan; 15(1):114-20. PubMed ID: 23178576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]